Cargando…

Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH

BACKGROUND: Chronic thromboembolic pulmonary hypertension (CTEPH) leads to right heart failure. Pulmonary endarterectomy (PEA) or balloon pulmonary angioplasty (BPA) restore pulmonary haemodynamics and allow cardiac recovery. This study examined the relationship of copeptin and mid-regional pro-atri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kriechbaum, Steffen D., Scherwitz, Lillith, Wiedenroth, Christoph B., Rudolph, Felix, Wolter, Jan-Sebastian, Haas, Moritz, Fischer-Rasokat, Ulrich, Rolf, Andreas, Hamm, Christian W., Mayer, Eckhard, Guth, Stefan, Keller, Till, Konstantinides, Stavros V., Lankeit, Mareike, Liebetrau, Christoph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7682678/ https://www.ncbi.nlm.nih.gov/pubmed/33263045 http://dx.doi.org/10.1183/23120541.00356-2020

Ejemplares similares

Pregnancy-associated plasma protein A – a new indicator of pulmonary vascular remodeling in chronic thromboembolic pulmonary hypertension?
por: Kriechbaum, Steffen D., et al.
Publicado: (2020)

Right Ventricular Strain by Magnetic Resonance Feature Tracking Is Largely Afterload-Dependent and Does Not Reflect Contractility: Validation by Combined Volumetry and Invasive Pressure Tracings
por: Rolf, Andreas, et al.
Publicado: (2022)

Cardiac biomarkers as indicators of right ventricular dysfunction and recovery in chronic thromboembolic pulmonary hypertension patients after balloon pulmonary angioplasty therapy – a cardiac magnetic resonance imaging cohort study
por: Kriechbaum, Steffen D., et al.
Publicado: (2021)

Sequential treatment with riociguat and balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension
por: Wiedenroth, Christoph B., et al.
Publicado: (2018)

Dynamics of high-sensitivity cardiac troponin T during therapy with balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Kriechbaum, Steffen D., et al.
Publicado: (2018)

Noninvasive prediction of pulmonary hemodynamics in chronic thromboembolic pulmonary hypertension by electrocardiogram-gated computed tomography
por: Roller, Fritz C., et al.
Publicado: (2021)

Exercise right heart catheterization before and after balloon pulmonary angioplasty in inoperable patients with chronic thromboembolic pulmonary hypertension
por: Wiedenroth, MD, Christoph B., et al.
Publicado: (2020)

Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation
por: Weferling, Maren, et al.
Publicado: (2021)

Non-Invasive Approach for Evaluation of Pulmonary Hypertension Using Extracellular Vesicle-Associated Small Non-Coding RNA
por: Lipps, Christoph, et al.
Publicado: (2019)

Current strategies for managing chronic thromboembolic pulmonary hypertension: results of the worldwide prospective CTEPH Registry
por: Guth, Stefan, et al.
Publicado: (2021)

Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS
por: Frøssing, Signe, et al.
Publicado: (2017)

Validation of a fast prognostic score for risk stratification of normotensive patients with acute pulmonary embolism
por: Hobohm, Lukas, et al.
Publicado: (2020)

Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany
por: Keller, Karsten, et al.
Publicado: (2020)

Time trends of pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension
por: Hobohm, Lukas, et al.
Publicado: (2021)

Chronic Thromboembolic Pulmonary Hypertension after Pulmonary Embolism, Thrombolysis, Catheter Fragmentation, and Embolectomy
por: Wiedenroth, Christoph B., et al.
Publicado: (2014)

Copeptin, Natriuretic Peptides, and Cardiovascular Outcomes in Patients With CKD: The German Chronic Kidney Disease (GCKD) Study
por: Schneider, Markus P., et al.
Publicado: (2023)

A simple score for rapid risk assessment of non-high-risk pulmonary embolism
por: Lankeit, Mareike, et al.
Publicado: (2012)

Circulating Monocyte Subsets Are Associated With Extent of Myocardial Injury but Not With Type of Myocardial Infarction
por: Askari, Noushin, et al.
Publicado: (2021)

Balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic disease
por: Wiedenroth, Christoph B., et al.
Publicado: (2017)

Riociguat in Patients with CTEPH and Advanced Age and/or Comorbidities
por: Barnikel, Michaela, et al.
Publicado: (2022)

NOVEL CTEPH MIMICKERS IN THE COVID-19 ERA
por: Pietrowicz, Rylie, et al.
Publicado: (2022)

Assessment of brain natriuretic peptide and copeptin as correlates of blood pressure in chronic hypertensive pregnant women
por: Okwor, Chika J., et al.
Publicado: (2022)

Native T1 is predictive of cardiovascular death/heart failure events and all-cause mortality irrespective of the patient’s volume status
por: Treiber, Julia, et al.
Publicado: (2023)

Prognostic value of copeptin and mid‐regional proadrenomedullin in COVID‐19‐hospitalized patients
por: Indirli, Rita, et al.
Publicado: (2022)

Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study
por: Möckel, Martin, et al.
Publicado: (2015)

Native T2 Predicts Myocardial Inflammation Irrespective of a Patient’s Volume Status
por: Wolter, Jan Sebastian, et al.
Publicado: (2023)

Central versus Peripheral CTEPH—Clinical and Hemodynamic Specifications
por: Kaldararova, Monika, et al.
Publicado: (2022)

Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis
por: Marti, Christophe, et al.
Publicado: (2015)

Outcome of patients with heart failure after transcatheter aortic valve implantation
por: Fischer-Rasokat, Ulrich, et al.
Publicado: (2019)

Regional extracellular volume within late gadolinium enhancement-positive myocardium to differentiate cardiac sarcoidosis from myocarditis of other etiology: a cardiovascular magnetic resonance study
por: Treiber, Julia, et al.
Publicado: (2023)

Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry
por: Giannitsis, Evangelos, et al.
Publicado: (2019)

Value of Right and Left Ventricular T1 and T2 Blood Pool Mapping in Patients with Chronic Thromboembolic Hypertension before and after Balloon Pulmonary Angioplasty
por: Roller, Fritz C., et al.
Publicado: (2023)

Long-Term Survival in Patients with or without Implantable Cardioverter Defibrillator after Transcatheter Aortic Valve Implantation
por: Fischer-Rasokat, Ulrich, et al.
Publicado: (2021)

Effects of exercise on serum ischemia-modified albumin, brain natriuretic peptide and copeptin levels in boxers and kick boxers
por: Memmedov, Hikmet, et al.
Publicado: (2022)

Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH)
por: Escribano-Subias, Pilar, et al.
Publicado: (2019)

Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic
por: Jansa, Pavel, et al.
Publicado: (2022)

CILP1 as a biomarker for right ventricular dysfunction in patients with ischemic cardiomyopathy
por: Keranov, Stanislav, et al.
Publicado: (2022)

High-sensitivity troponin I for risk stratification in normotensive pulmonary embolism
por: Ebner, Matthias, et al.
Publicado: (2020)

Real-World Switching to Riociguat: Management and Practicalities in Patients with PAH and CTEPH
por: Gall, Henning, et al.
Publicado: (2018)

Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH
por: Benza, Raymond L., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n9hee2dpin0mq0935l05igtg41